Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity (Q39606015)

13 September 2017

title

Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity (English)

1 reference

13 September 2017

6

1 reference

13 September 2017

1

Mikkel Harndahl

1 reference

13 September 2017

Michael Rasmussen

2

1 reference

13 September 2017

Gustav Roder

3

1 reference

13 September 2017

Ida Dalgaard Pedersen

4

1 reference

13 September 2017

Mikael Sørensen

5

1 reference

13 September 2017

Søren Buus

7

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 June 2012

1 reference

European Journal of Immunology

13 September 2017

published in

1 reference

13 September 2017

volume

42

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

1405-1416

1 reference

The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Thermodynamic and Kinetic Analysis of a Peptide−Class I MHC Interaction Highlights the Noncovalent Nature and Conformational Dynamics of the Class I Heterotrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Selecting informative data for developing peptide-MHC binding predictors using a query by committee approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Peptide selection by MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Cut and trim: generating MHC class I peptide ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Secondary anchor polymorphism in the HA-1 minor histocompatibility antigen critically affects MHC stability and TCR recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Relationship between kinetic stability and immunogenicity of HLA-DR4/peptide complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Improved immunogenicity of an immunodominant epitope of the HER-2/neu protooncogene by alterations of MHC contact residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

One-pot, mix-and-read peptide-MHC tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: a novel strategy exploiting disulfide assisted protein folding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

A naturally processed epitope on rotavirus VP7 glycoprotein recognized by HLA-A2.1-restricted cytotoxic CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Reliable prediction of T-cell epitopes using neural networks with novel sequence representations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

The impact of HLA-B micropolymorphism outside primary peptide anchor pockets on the CTL response to CMV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FEJI.201141774

21 January 2018

https://api.crossref.org/works/10.1002%2FEJI.201141774

7 January 2021

Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

7 January 2021

High peptide affinity for MHC class I does not correlate with immunodominance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

7 January 2021

Use of fluorescence polarization to monitor MHC-peptide interactions in solution

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

7 January 2021

Measuring interactions of MHC class I molecules using surface plasmon resonance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

7 January 2021

Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141774

7 January 2021

Identifiers

DOI

10.1002/EJI.201141774

1 reference

13 September 2017

1 reference